Explore the full record of transactions filed by Bodenstedt Matthias, Chief Financial Officer. Officer active across 1 companies, notably MoonLake Immunotherapeutics. Cumulatively, 2 disclosures have been recorded. Total volume traded: €464k. The latest transaction was disclosed on 11 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Matthias Bodenstedt serves as the Chief Financial Officer at MoonLake Immunotherapeutics. In this role, he oversees the company's financial operations, including budgeting and financial reporting. His expertise in finance and management enables him to contribute to the financial strategy and growth of MoonLake. He plays a vital role in managing the company's financial resources.